Ramin Valian

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image illustrating an advanced AI system operating software autonomously, reflecting the Macrohard project unveiled by Tesla, Inc. and xAI, which Elon Musk claims could replicate the full operational functions of software companies using agentic artificial intelligence.

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Representative image illustrating a drone flying over California as reports reveal that Iran allegedly considered a surprise drone strike on targets in the state, according to a Federal Bureau of Investigation intelligence bulletin disclosed during the ongoing United States–Iran conflict.

Iran planned surprise drone strike on California, FBI bulletin reveals

Palantir Technologies (NASDAQ: PLTR) expands Asia enterprise push through LG CNS partnership

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Emmecell names ex-AbbVie executive Ramin Valian as CEO to lead cell therapy platform

Emmecell names Ramin Valian as CEO to guide its magnetic cell delivery platform toward pivotal trials. Find out what this leadership shift means for the industry.

bySrinath

January 18, 2026

Emmecell taps AbbVie veteran Ramin Valian as CEO to lead magnetic cell therapy into pivotal trials

Emmecell has named former AbbVie executive Ramin Valian as CEO to lead its magnetic cell therapy platform into pivotal trials. Find out what this signals next.

byPallavi Madhiraju

January 17, 2026

The Latest

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Iran planned surprise drone strike on California, FBI bulletin reveals

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Emmecell names ex-AbbVie executive Ramin Valian as CEO to lead cell therapy platform

Emmecell taps AbbVie veteran Ramin Valian as CEO to lead magnetic cell therapy into pivotal trials

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Iran planned surprise drone strike on California, FBI bulletin reveals

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release

The sub-1nm race is heating up and IBM and Lam Research just made their move

Iran: Get ready for $200 oil. IRGC fires on more ships in the Gulf

Haleon (NYSE, LSE: HLN) bets on China’s oral health boom with £65m Shanghai manufacturing facility